Ricardo Parrondo

Also affiliated with WinnMed, Nemours Children’s Clinic, Mayo Clinic in Florida, Nemours Children's Clinic

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation”.

Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.10.022

N/A

0DataRank · unranked

20 citations

Shaji Kumar, Raphael Fraser, Noel Estrada‐Merly, Sergio Giralt, Vaibhav Agrawal +22 more

Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas

Blood(2023)10.1182/blood.2023021187

N/A

0DataRank · unranked

14 citations

Shaji Kumar, Linda B. Baughn, Angela Dispenzieri, Patricia T. Greipp, Rhett P. Ketterling +28 more

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Blood(2024)10.1182/blood.2024025945

N/A

0DataRank · unranked

130 citations

Krina K. Patel, Lauren C. Peres, Radhika Bansal, Mehmet H. Kocoglu, Leyla Shune +33 more

Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study

Blood Cancer Journal(2025)10.1038/s41408-025-01259-z

N/A

0DataRank · unranked

34 citations

Sireesha Asoori, Chiung‐Yu Huang, Larissa Brunaldi, Rakesh Popat, Efstathios Kastritis +19 more

Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.10.003

N/A

0DataRank · unranked

2 citations

Timothy T. Xu, Suheil Albert Atallah‐Yunes, Kenneth J C Lim, Sikander Ailawadhi, Ricardo Parrondo +17 more